Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bast

Showing results (211-220 of 560) with videos related to

Pageof 56
Sort By:
Cell Cycle (Georgetown, Tex.)|November 26, 2008
Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2Xiao-Feng Le, Weiqun Mao, Chunhua Lu, et al.
Oncogene|January 30, 2003
Paclitaxel induces inactivation of p70 S6 kinase and phosphorylation of Thr421 and Ser424 via multiple signaling pathways in mitosisXiao-Feng Le, Walter N Hittelman, Jiaxin Liu, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1983
Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125S E Kabawat, R C Bast, A K Bhan, et al.
Cancers|June 12, 2026
Targeting SIK2 with GRN-300 Potentiates Paclitaxel Efficacy in Triple-Negative Breast CancerMarc A Pina, Rumeysa Ozyurt, Weiqun Mao, et al.
American Journal of Obstetrics and Gynecology|October 1, 1990
Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinomaJ T Soper, A Berchuck, G J Olt, et al.
Obstetrics and Gynecology|July 11, 1992
Prospective evaluation of serum CA 125 levels for early detection of ovarian cancerN Einhorn, K Sjövall, R C Knapp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 1992
Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigenL Daly, J Ferguson, G P Cram, et al.
Gynecologic Oncology|October 29, 1998
A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancerD M Gershenson, T W Burke, M Morris, et al.
Gynecologic Oncology|November 15, 2008
Urinary levels of Bcl-2 are elevated in ovarian cancer patientsNicole S Anderson, Yira Bermudez, Donna Badgwell, et al.
Cancer Research|February 1, 1985
Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complementR C Bast, P De Fabritiis, J Lipton, et al.
Pageof 56

Showing results (211-220 of 560) with videos related to

Sort By:
Pageof 56
Cell Cycle (Georgetown, Tex.)|November 26, 2008
Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2Xiao-Feng Le, Weiqun Mao, Chunhua Lu, et al.
Oncogene|January 30, 2003
Paclitaxel induces inactivation of p70 S6 kinase and phosphorylation of Thr421 and Ser424 via multiple signaling pathways in mitosisXiao-Feng Le, Walter N Hittelman, Jiaxin Liu, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1983
Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125S E Kabawat, R C Bast, A K Bhan, et al.
Cancers|June 12, 2026
Targeting SIK2 with GRN-300 Potentiates Paclitaxel Efficacy in Triple-Negative Breast CancerMarc A Pina, Rumeysa Ozyurt, Weiqun Mao, et al.
American Journal of Obstetrics and Gynecology|October 1, 1990
Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinomaJ T Soper, A Berchuck, G J Olt, et al.
Obstetrics and Gynecology|July 11, 1992
Prospective evaluation of serum CA 125 levels for early detection of ovarian cancerN Einhorn, K Sjövall, R C Knapp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 1992
Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigenL Daly, J Ferguson, G P Cram, et al.
Gynecologic Oncology|October 29, 1998
A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancerD M Gershenson, T W Burke, M Morris, et al.
Gynecologic Oncology|November 15, 2008
Urinary levels of Bcl-2 are elevated in ovarian cancer patientsNicole S Anderson, Yira Bermudez, Donna Badgwell, et al.
Cancer Research|February 1, 1985
Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complementR C Bast, P De Fabritiis, J Lipton, et al.
Pageof 56